Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
0.4691
+0.0308 (7.03%)
At close: Nov 26, 2025, 4:00 PM EST
0.4790
+0.0099 (2.11%)
After-hours: Nov 26, 2025, 7:48 PM EST
Iterum Therapeutics Market Cap
Iterum Therapeutics has a market cap or net worth of $24.76 million as of November 26, 2025. Its market cap has decreased by -21.54% in one year.
Market Cap
24.76M
Enterprise Value
47.50M
1-Year Change
-21.54%
Ranking
Category
Stock Price
$0.47
Market Cap Chart
Since May 25, 2018, Iterum Therapeutics's market cap has decreased from $179.38M to $24.76M, a decrease of -86.20%. That is a compound annual growth rate of -23.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 24.76M | -49.16% |
| Dec 31, 2024 | 48.70M | 84.01% |
| Dec 29, 2023 | 26.47M | 157.57% |
| Dec 30, 2022 | 10.28M | -85.65% |
| Dec 31, 2021 | 71.61M | 47.53% |
| Dec 31, 2020 | 48.54M | -27.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |